Medical Health & Life Science Research News

Asia Pacific sepsis diagnostics market is growing at 10.5% CAGR between 2016 to 2021

Asia Pacific sepsis diagnostics market is growing at 10.5% CAGR between 2016 to 2021

The Asia Pacific Sepsis Diagnostics Market was worth USD 59.2 million in 2016 and estimated to be growing at a CAGR of 10.5%, to reach USD 97.53 million by 2021. The increasing prevalence of the disease and its fatal affects has stimulated its growth.

- Advertising -

According to the report “Asia Pacific Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, 

Browse report details @ www.marketdataforecast.com/market-…tics-market-2949/

Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds.

- Advertising -

It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis.

Major driving forces of the Asia Pacific Sepsis Diagnostics Market are increasing geriatric population, rising prevalence of different antibiotic resistant bacterial strains, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. But, factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to hinder the growth of market.

The Asia Pacific Sepsis Diagnostics Market is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal.

Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry.

Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing.

Request Free Sample Market Brochure of the report @ www.marketdataforecast.com/market-…49/request-sample

Based on Geographical analysis the Asia Pacific Sepsis Diagnostics Market is separated into regions of China, India, Japan, South-Korea and Australia. China is leading the market while India is at second place.

Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped China dominate the market. India is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.

Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment.

Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.

Some of the key players dominating this Asia Pacific Sepsis Diagnostics Market:

  • BioMérieux SA
  • T2 Biosystem Inc
  • Cepheid
  • Thermo Fisher Scientific Inc.
  • Nanosphere Inc
  • Abbott Laboratories
  • Roche Diagnostics Limited
  • Becton & Dickinson and Company
  • Bruker Corporation
  • Beckman Coulter, Inc.

Make an Inquiry  @ www.marketdataforecast.com/market-…rket-2949/inquire

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...